The Food and Drug Administration has cleared an ultrasound bladder scanner made by Norwegian firm Vitacon AS to diagnose bladder dysfunction and the firm has signed a marketing agreement that will launch the product in the U.S.
The VitaScan LT USB Scanner is an alternative to measuring bladder volume using urethral catheters, the company said in a news release. Treatment for urinary tract infections acquired in the hospital through the use of the catheter is no longer reimbursed by Medicare, which makes Vitacon’s product attractive, the company implied in a news release.
To make this product available for U.S. patients suffering from incontinence and other bladder problems, Vitacon is signing a marketing and distribution agreement with Minneapolis-based life sciences advisory firm Salus Consilium.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The VitaScan also has USB capability so that data collected on bladder functioning can be transmitted to laptops and tablets.
